Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Introducing Olivier Midy, A New Genderless Skincare Line Building on 300 Years of Science and Innovation

The Eponymous Skincare Brand Launches with Éclat Midy, a Luxurious, Multi-Correctional Face Oil from 18 Proven, Plant-Based Ingredients


News provided by

Olivier Midy

Nov 17, 2021, 11:00 ET

Share this article

Share toX

Share this article

Share toX

Éclat Midy, the premier luxury face oil from Olivier Midy
Éclat Midy, the premier luxury face oil from Olivier Midy

LOS ANGELES, Nov. 17, 2021 /PRNewswire-PRWeb/ -- Olivier Midy, a descendant of the oldest pharmaceutical family in the world, announces the launch of a new clean, clinical, and vegan skincare line under his own name, Olivier Midy, LLC. The brand's premier product is a multi-correctional face-oil called Éclat Midy.

The original "Laboratoires Midy" was founded in 1718, by Olivier's great grandfather, François Midy, an apothecary surgeon. Olivier created the eponymous skincare line to pay homage to his rich family history. "We are a trusted family name that dates back over 10 consecutive generations; this brand, the products, and the science behind it celebrate over 300 years of innovation," said Midy.

“Every element of our skincare line embraces quality and innovation. From the scientific approach which includes our use of plant-based ingredients and safe synthetics to our packaging, a symbol of style, sophistication, to our iconic name, which is recognized all over." - Olivier Midy, Founder

Post this

As with his family's original company, research and innovation are the hallmarks of the brand, which focuses on safe and effective skincare solutions that utilize plant-based technology. Every ingredient follows the strictest standards for skincare safety, as set forth by the EU, for results that deliver and are truly healthy for your skin.

"Every aspect, every element, and every step of our skincare line embraces quality and innovation. From the scientific approach which includes our use of plant-based ingredients and safe synthetics to our packaging, a symbol of style, sophistication, to our iconic name, which is recognized all over the world," said Midy.

Olivier Midy's first product, Éclat Midy, is formulated with 18 seed oils and plant extracts. This nutrient-rich oil helps restore skin's vitality and boosts healthier, more radiant-looking skin. Using extracts from Meadowfoam, Sea Buckthorn, Moringa, Microalgae, and Sandalwood the formula is powered by the rare Omega 7 and Omega 6, known for their regenerative properties. The golden-hued oil also gains powerful properties from Astaxanthin, which is 800 times stronger than COQ10, and 6000 times stronger than vitamin C, helping increase cell turnover, restore elasticity, and increase collagen synthesis. Rich in antioxidants, the oil also acts as a strong anti-inflammatory agent, fighting free radicals, blemishes, and dark spots. This crafted blend is true nutrition for your skin, helping it look and feel its best.

Éclat Midy and all Olivier Midy products will be available exclusively from the brand's website, OlivierMidy.com

About Olivier Midy
The Midy name is synonymous with the Parisian aesthetic and scientific innovation. Labatories Midy was originally founded in 1718 by Francois Midy, an apothecary surgeon who advanced the use of biological actives in exotic plants from around the world by harnessing their healing properties. With his work, Francois Midy created France's most recognized pharmacy—and laid the foundation for today's modern pharmaceutical industry.

Seven subsequent generations later, Olivier Midy is carrying on his family's legacy with his eponymous skin care line: Olivier Midy. Everything from the packaging to product design will honor the Midy legacy of tradition, science, and innovation.

About Éclat Midy
Éclat Midy is Olivier Midy's first product, a gender-free, nourishing oil that helps restore skin's health and vitality, instantly transforming a dull complexion into healthier, more radiant-looking skin. With clean, plant-based, and anti-aging ingredients, its power-packed formula helps lock in moisture, improve elasticity, and increase collagen synthesis. And because it's rich in antioxidants and acts as a strong anti-inflammatory agent, it fights free radicals, blemishes, and dark spots.

About the Founder
Born in Paris, Olivier Midy moved to Aspen at a young age where he was raised an avid skier, hiker, and outdoorsman. He began his career as an art dealer working primarily with contemporary artists. Wanting to pay tribute to his father who passed away when he was little and taps into a storied family heritage he always knew was there, he was inspired to deepen his research on the Midy family name and launch a new skincare line in the tradition of their original french pharmaceutical company, Laboratories Midy. After spending years studying history and formulations and tracking down artifacts from the original company, Olivier Midy was born as a way to honor and pass on this rich, family legacy to his daughter.

Press Contact: [email protected]

OlivierMidy.com // IG: @maisonmidy

Media Contact

Emily Burniston, The No 29, +1 973-868-7182, [email protected]

SOURCE Olivier Midy

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.